Table 3.
Items Groups |
Perioperative period |
||||
A | B | C | D | ||
CD3 | Treatment | 60.8 ± 6.3 | 63.0 ± 4.9d | 60.3 ± 5.4a | 64.2 ± 3.9d |
Control | 60.5 ± 4.6 | 61.0 ± 2.7 | 56.2 ± 3.8bd | 58.6 ± 4.0ab | |
CD4 | Treatment | 33.6 ± 4.2 | 36.3 ± 3.4a | 32.8 ± 4.0d | 36.6 ± 6.2d |
Control | 33.4 ± 3.7 | 32.8 ± 3.3b | 28.1 ± 3.4bd | 30.4 ± 3.3ab | |
CD8 | Treatment | 30.6 ± 5.2 | 29.6 ± 4.3 | 31.1 ± 4.3 | 29.4 ± 3.6 |
Control | 31.0 ± 3.9 | 31.2 ± 4.8 | 32.9 ± 4.4a | 32.1 ± 5.3 | |
CD57+ | Treatment | 14.8 ± 4.4 | 15.7 ± 3.8 | 17.2 ± 3.7 | 21.1 ± 4.5b |
Control | 15.0 ± 2.8 | 13.1 ± 2.5 | 14.2 ± 2.2b | 15.6 ± 1.7b | |
CD4 | Treatment | 1.15 ± 0.34 | 1.25 ± 0.23a | 1.08 ± 0.21d | 1.27 ± 0.30d |
/CD8 | Control | 1.11 ± 0.25 | 1.08 ± 0.22b | 0.87 ± 0.17bd | 0.98 ± 0.24ab |
A: at admission, B: before operation, C: on the 2nd postopera-tive day, D: on the 10th postoperative day.
P < 0.05,
P < 0.01, B vs A, C vs B, D vs C;
P < 0.01 vs treatment group.